Cas:60770-60-7 5-Fluoro-2,3-dihydro-1-benzofuran-3-ol manufacturer & supplier

Chemical Name:5-Fluoro-2,3-dihydro-1-benzofuran-3-ol

CAS.NO:60770-60-7

Synonyms:5-fluoro-2,3-dihydrobenzofuran-3-ol;3-Benzofuranol,5-fluoro-2,3-dihydro;5-Fluor-3-hydroxy-2,3-dihydrobenzo<b>furan

Molecular Formula:C₈H₇FO₂

Molecular Weight:154.13800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.46000

Exact Mass:154.04300

LogP:1.25150

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-fluoro-2,3-dihydrobenzofuran-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,furan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,b&gt Use and application,5-Fluor-3-hydroxy-2,3-dihydrobenzo&lt technical grade,usp/ep/jp grade.

Related News: Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 5-Fluoro-2,3-dihydro-1-benzofuran-3-ol manufacturer We manufacture APIs and drug manufacturers make medicines from APIs. 5-Fluoro-2,3-dihydro-1-benzofuran-3-ol supplier From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 5-Fluoro-2,3-dihydro-1-benzofuran-3-ol vendor The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. 5-Fluoro-2,3-dihydro-1-benzofuran-3-ol factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.